Array BioPharma and Genentech Form Another Cancer Collaboration
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 8 (Table of Contents)
Published: 19 Aug-2011
DOI: 10.3833/pdr.v2011.i8.1526 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Array BioPharma and Genentech have expanded their relationship in oncology by forming a second collaboration to develop both company’s small molecule checkpoint kinase 1 (ChK-1) programmes, which include Genentech’s Phase 1 GDC-0425 and Array’s preclinical-stage ARRY-575...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018